Home > Back to Publisher > Report Information

Chinese Markets for Ovarian Cancer Treatment Drugs

Asia Market Information & Development Company
April 1, 2009
243 Pages - SKU: ASM2222288

Abstract Table of Contents Related Reports

Countries covered: China

China's demand for Ovarian Cancer Treatment Drugs has grown at a fast pace in the past decade. In the next five years, both production and demand will continue to grow. This new study examines China's economic trends, investment environment, industry development, supply and demand, industry capacity, industry structure, marketing channels and major industry participants. Historical data (1998, 2003 and 2008) and long-term forecasts throught 2013 and 2018 are presented. Major producers in China are profiled.

I. INTRODUCTION: Report Scope and Methodology; Executive Summary
II. BUSINESS ENVIRONMENT: Economic Outlook; Key Economic Indicators; Industrial Output; Population and Labor; Foreign Investment; Foreign Trade; Financial and Tax Regulations; Banking System and Regulations; Foreign Exchange; Taxes, Tariff and Custom Duties
III. OVARIAN CANCER TREATMENT DRUGS INDUSTRY ASSESSMENTS: Ovarian Cancer Treatment Drugs Industry Structure; Market Size; Market Growth Driver; Ovarian Cancer Treatment Drugs Sales Volume; Major Producer Facility Locations; Major Producersf Sales Volume and Market Share; Paclitaxel; Platinum Anticancer Drugs; Fluoropyrimidines; Anthracycline Antibiotics; Therapertic Antibody; Small Molecules Drug; Aromatase Inhibitors (Targeted Therapy Drug); Anti-estrogens; Aromatase Inhibitors (Endocrine Therapy Drug); LH-RH; Labor Cost; Potential Entrants; Major Distributors; Major Foreign Investments; Technology Development
IV. OVARIAN CANCER TREATMENT DRUGS PRODUCTION AND DEMAND: Overview; Ovarian Cancer Treatment Drugs Sales Volume; Chemotherapeutic Drug; Paclitaxel; Fluoropyrimidines; Anthracycline Antibiotics; Platinum Anticancer Drugs; Targeted Therapy Drug; Therapertic Antibody; Small Molecules Drug; Aromatase Inhibitors (Targeted Therapy Drug); Endocrine Therapy Drug; Anti-estrogens; Aromatase Inhibitors (Endocrine Therapy Drug); LH|RH; Ovarian Cancer Treatment Drugs Import; Chemotherapeutic Drug; Paclitaxel; Fluoropyrimidines; Anthracycline Antibiotics; Platinum Anticancer Drugs; Targeted Therapy Drug; Therapertic Antibody; Small Molecules Drug; Aromatase Inhibitors (Targeted Therapy Drug); Endocrine Therapy Drug; Anti-estrogens; Aromatase Inhibitors (Endocrine Therapy Drug); LH|RH; Pricing Trend
V. OVARIAN CANCER TREATMENT DRUGS MARKET OUTLOOK: Ovarian Cancer Treatment Drugs Markets Outlook Overview Concrete Government Regulations; Health Care Insurance Industry Overview; Consumer Spending Trends; Demographic Trends; Health Care Industry Trends; Hospitals and Hospital Beds; Physicians and Physician Visits
VI. MARKET ENTRY CHANNELS: China Market Entry Overview; Chinafs Distribution System; Ovarian Cancer Treatment Drugs Distribution Channels; Transportation and Freight Infrastructure; Communications; Chinafs Market Entry; Export to China; Indirect export; Direct Export; License and Contract Manufacture; Assembling in China; Contract Manufacturing; Trade Permit; Investment; Equity Joint Venture; Contractual Joint Venture; Wholly Foreign-Owned Enterprise
VII. ANTIFREEZE & THAWING AGENT PRODUCER DIRECTORY: Ovarian Cancer Treatment Drugs Producer Profiles and Directory
LIST OF TABLES
I. INTRODUCTION: Economic Outlook Summary
II. BUSINESS ENVIRONMENT: Key Economic Indicators; Industrial Output; Population and Labor Force Trends; Foreign Investment and Loans; Foreign Trade
III. OVARIAN CANCER TREATMENT DRUGS INDUSTRY ASSESSMENTS: Ovarian Cancer Treatment Drugs Sales Volume; Chemotherapeutic Drug Sales Volume and Market Share by Drugs Classification; Targeted Therapy Drug Sales Volume and Market Share by Drugs Classification; Endocrine Therapy Drug Sales Volume and Market Share by Drugs Classification; Major Producer Facility Locations; Major Ovarian Cancer Treatment Drugs Producer Sales Volume and Market Share; Major Foreign Investments
IV. OVARIAN CANCER TREATMENT DRUGS PRODUCTION AND DEMAND: Total Ovarian Cancer Treatment Drugs Sales Volume; Ovarian Cancer Treatment Drugs Major Producer and Their Market Share; Chemotherapeutic Drug Sales Volume and Market Share by Drugs Classification; Chemotherapeutic Drug Major Producer and Their Market Share; Paclitaxel Major Producer and Their Market Share; Fluoropyrimidines Major Producer and Their Market Share; Anthracycline Antibiotics Major Producer and Their Market Share; Platinum Anticancer Drugs Major Producer and Their Market Share; Targeted Therapy Drug Sales Volume and Market Share by Drugs Classification; Targeted Therapy Drug Major Producer and Their Market Share; Therapertic Antibody Major Producer and Their Market Share; Small Molecules Drug Major Producer and Their Market Share; Aromatase Inhibitors (Targeted Therapy Drug) Major Producer and Their Market Share; Endocrine Therapy Drug Sales Volume and Market Share by Drugs Classification; Endocrine Therapy Drug Major Producer and Their Market Share; Anti-estrogens Major Producer and Their Market Share; Aromatase Inhibitors (Endocrine Therapy Drug) Major Producer and Their Market Share; LH|RH Major Producer and Their Market Share; Ovarian Cancer Treatment Drugs Import
V. OVARIAN CANCER TREATMENT DRUGS MARKET OUTLOOK: Consumer Spending Trends; Demographic Trends; Health Care Industry Trends; Hospitals and Hospital Beds; Physicians and Physician Visits
LIST OF CHARTS
I. INTRODUCTION: Ovarian Cancer Treatment Drugs Sales Volume

More China Reproductive Health Reports

Emergency Contraception in China by Euromonitor International
Sales of emergency contraception market saw growth of 8% in current value terms in 2011. Owing to public’s concern about the side effects of emergency ...

Research Report on China's Condom Industry 2011-2012 by China Research and Intelligence Co., Ltd.
With the popularization of concepts and knowledge of reproductive health as well as the improvement of people's living standard, the condom use rate shows the ...

Emergency Contraception - China by Euromonitor International
The emergency contraception market in 2010 enjoyed 9% current value growth, higher than the 7% growth in 2009. Although a scandal concerning the side effects ...

Report on China’s Oral Contraceptive Drugs Industry by SunFAITH China Ltd.
Oral contraceptive drug has two major components: progesterone and estrogen, which achieve contraception by taking effects on physiology. Through detailed data analysis, this article is ...

The 2009-2014 Outlook for Contraceptives in Greater China by Icon Group International, Inc.
This econometric study covers the latent demand outlook for contraceptives across the regions of Greater China, including provinces, autonomous regions (Guangxi, Nei Mongol, Ningxia, Xinjiang, ...

See all reports like this >>

More China Reports

D&B Country RiskLine Report: China by Dun & Bradstreet Inc.
This D&B Country RiskLine Report will help you analyze the risks, opportunities and likely payment delays when doing business in this country. It includes ...

Country Report China February 2011 by Economist Intelligence Unit
Country Reports analyse political and economic trends in featured countries. They show you exactly how national, regional and global events will affect your business in ...

Country Report China January 2011 by Economist Intelligence Unit
Country Reports analyse political and economic trends in featured countries. They show you exactly how national, regional and global events will affect your business in ...

D&B Country Report: China by Dun & Bradstreet Inc.
D&B Country Report. Comprehensive information for evaluating risks and opportunities when trading or investing in this country. Providing critical information and analysis on ...

Juice – China – a snapshot (2010) by Mintel - Snapshots
Juice in China by Mintel Global Market Navigator provides you with annual year-end market size data, most recently updated in 2010. The report covers packaged ...

See all reports like this >>

Chinese Markets for Ovarian Cancer Treatment Drugs

Share this report

Other tasks

Research Assistance

Related Markets

Reproductive Health Reports

Free Alert Me service